Early Alzheimer’s diagnosis compound | Chemistry World - Alzheimer’s disease is the most common form of dementia and, as there is no cure, early diagnosis is crucial for treatment to be effective. To this end, UK and US scientists have developed a labelled tracer compound that binds to plaques closely associated with Alzheimer’s disease (AD) so that the plaques can be picked up by a medical imaging technique.(10.1039/c2cc38443d)
Email Newsletter
Slinn Pickings
ChemSpy.com is owned and operated by science journalist David Bradley. Additional chemistry news updates are posted by chemist Robert Slinn CChem MRSC MPhil with the tag: Slinn Pickings.




About